Company Overview of Acretia, Inc.
Acretia, Inc., a drug development company, engages in the development of a product for hyper-proliferative inflammatory diseases of the skin. It focuses on the late stage biopharmaceutical compounds. The company identifies and acquires pharmaceutical products from medical institutions; establishes partnerships with biotechnology and pharmaceutical companies to validate the clinical utility of its products; and commercializes and markets via alliances with pharmaceutical partners. It also develops products targeting unmet needs in relieving pain. The company was incorporated in 2003 and is based in Lexington, Massachusetts.
51 Follen Road
Lexington, MA 02421
Founded in 2003
Key Executives for Acretia, Inc.
Similar Private Companies By Industry
|Montana Microbial Products LLC||United States|
|Egalet, Ltd.||United States|
|Item Group||United States|
|Wilmington Pharmaceuticals, LLC||United States|
|Sony Biotechnology Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- New Brunswick, NJ | Tridiagonal SolutionsPosted: Apr 24
- Louisville, KY | AstraZenecaPosted: May 21
- Field, KY | Shire PharmaceuticalsPosted: May 18
Sponsored Financial Commentaries
To contact Acretia, Inc., please visit www.acretia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.